Medtronic faces a busy year with three major product launches expected, including a wireless heart-monitoring sensor, its Endeavor drug-coated stent and the first artificial spine disc that allows full mobility. Analysts tend to be bullish given the company's diversity and past sales and earnings track record.

Full Story:

Related Summaries